ECNP 2018: The GABAA Modulator SAGE-217 Appears Effective and Well Tolerated for Depression
This modulator of GABAA receptors represents a new mechanism of action in antidepressant therapy.
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.